Yasmin Sheikh, head of policy and public affairs at Anthony Nolan, said: “We’re pleased to see NHS England embracing new technology that could help reduce deaths from sepsis.
“Patients who receive a CAR T-cell therapy or stem cell transplant are particularly vulnerable to infection, which continues to be a major cause of transplant-related death.
“Technology like this could help more patients recover safely and comfortably at home, and support the NHS to manage the risks of infection for vulnerable patients.”
Contact details are available to account holders.
Create a free account to get in touch with this expert.